RT Journal Article
SR Electronic
T1 A Genetic Perspective on Diabetic Complications: A Mendelian Randomization Study on the Increased Risk of Cataracts in Type 1 Diabetes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.29.24301964
DO 10.1101/2024.01.29.24301964
A1 Pei, Dongliang
A1 Wang, Shuyan
A1 Wang, Yuan
A1 Sun, Chenmin
YR 2024
UL http://medrxiv.org/content/early/2024/01/30/2024.01.29.24301964.abstract
AB Background The well-documented epidemiological link between type 1 diabetes and cataract is recognized. Yet, the question of a shared genetic foundation for these conditions, and the potential implication of a causal connection, is still an area of uncertainty.Methods We utilized a two-sample Mendelian randomization approach to extract and analyze four GWAS datasets from public databases, aiming to elucidate the causal relationship between Type 1 Diabetes and cataracts. Our study design incorporated multiple Mendelian randomization methods to assess the influence of Type 1 Diabetes genetic risk on the susceptibility to cataracts, and employed the MR-PRESSO global test for the evaluation of horizontal heterogeneity among the results.Results Mendelian Randomization analysis has indicated a statistically significant association between Type 1 Diabetes and an increased risk of cataract development. All applied Mendelian Randomization methods pointed to a positive causal estimate, suggesting that Type 1 Diabetes contributes to an elevated risk of cataracts.Conclusion This study supports the hypothesis of a causal relationship between Type 1 Diabetes and cataracts. Despite some heterogeneity, all outcomes are positively aligned, and leave-one-out analysis confirms the robustness of these findings. This research is significant for understanding the process of cataract prevention and treatment in patients with Type 1 Diabetes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study, a Mendelian Randomization analysis, utilized data exclusively from public databases. Given the public and de-identified nature of the data, institutional ethical review and approval were not required for this research. The datasets were accessed in accordance with the terms and conditions of their respective sources.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files.